ME02668B - Postupak za izdvajanje nalmefen hidrohlorida - Google Patents

Postupak za izdvajanje nalmefen hidrohlorida

Info

Publication number
ME02668B
ME02668B MEP-2017-75A MEP201775A ME02668B ME 02668 B ME02668 B ME 02668B ME P201775 A MEP201775 A ME P201775A ME 02668 B ME02668 B ME 02668B
Authority
ME
Montenegro
Prior art keywords
phase
nalmefene hydrochloride
aqueous composition
process according
aqueous
Prior art date
Application number
MEP-2017-75A
Other languages
German (de)
English (en)
French (fr)
Unknown language (me)
Inventor
Faveri Carla De
Mariano Stivanello
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02668(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of ME02668B publication Critical patent/ME02668B/me

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MEP-2017-75A 2011-12-06 2012-12-06 Postupak za izdvajanje nalmefen hidrohlorida ME02668B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567148P 2011-12-06 2011-12-06
DKPA201100948 2011-12-06
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride
EP12797909.4A EP2788357B1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (1)

Publication Number Publication Date
ME02668B true ME02668B (me) 2017-06-20

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2017-75A ME02668B (me) 2011-12-06 2012-12-06 Postupak za izdvajanje nalmefen hidrohlorida

Country Status (32)

Country Link
US (1) US8841452B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2788357B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP6086925B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20140103288A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN104093721B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR089080A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2012347261B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112014013541B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2857096C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CL (1) CL2014001454A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO6970605A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1118785T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK2788357T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2622156T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20170497T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUE033717T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL232826A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014KN01211A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JO (1) JO3251B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LT (1) LT2788357T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (1) ME02668B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX354331B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL2788357T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT2788357T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (1) RS55817B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2631652C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG11201402956UA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI2788357T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SM (1) SMT201700200T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI560170B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013083685A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201404100B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
US20240109907A1 (en) 2021-01-28 2024-04-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3896226A (en) * 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
DE60045695D1 (de) * 1999-11-09 2011-04-14 Abbott Lab Hydromorphinonzusammensetzungen
CA2748620C (en) * 2002-03-14 2014-03-11 Euro-Celtique, S.A. Naltrexone hydrochloride compositions
EP1994034B1 (en) * 2006-03-02 2009-11-11 Mallinckrodt, Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
AU2007329453B2 (en) * 2006-12-04 2013-04-04 Noramco, Llc Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
EP2121669A2 (en) 2007-01-30 2009-11-25 Biogen Idec MA, Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2010136039A1 (en) 2009-05-25 2010-12-02 H. Lundbeck A/S Preparation of nalmefene hydrochloride from naltrexone
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
CL2014001454A1 (es) 2014-10-03
SG11201402956UA (en) 2014-07-30
IL232826A (en) 2016-10-31
AU2012347261A1 (en) 2014-06-19
US20140296525A1 (en) 2014-10-02
EP2788357A1 (en) 2014-10-15
DK2788357T3 (en) 2017-04-24
SI2788357T1 (sl) 2017-06-30
EP2788357B1 (en) 2017-03-01
BR112014013541A2 (pt) 2017-06-13
HRP20170497T1 (hr) 2017-06-02
MX354331B (es) 2018-02-27
TWI560170B (en) 2016-12-01
HUE033717T2 (en) 2017-12-28
HK1202874A1 (en) 2015-10-09
AR089080A1 (es) 2014-07-30
WO2013083685A1 (en) 2013-06-13
PL2788357T3 (pl) 2017-07-31
IL232826A0 (en) 2014-08-03
ES2622156T3 (es) 2017-07-05
CA2857096C (en) 2021-01-19
CA2857096A1 (en) 2013-06-13
JP2015504856A (ja) 2015-02-16
RS55817B1 (sr) 2017-08-31
JP6086925B2 (ja) 2017-03-01
TW201335110A (zh) 2013-09-01
CY1118785T1 (el) 2017-07-12
JO3251B1 (ar) 2018-09-16
US8841452B1 (en) 2014-09-23
CN104093721A (zh) 2014-10-08
RU2631652C2 (ru) 2017-09-26
RU2014126489A (ru) 2016-01-27
BR112014013541B1 (pt) 2022-02-15
CO6970605A2 (es) 2014-06-13
SMT201700200T1 (it) 2017-05-08
MX2014006705A (es) 2014-07-09
LT2788357T (lt) 2017-04-25
KR20140103288A (ko) 2014-08-26
PT2788357T (pt) 2017-04-24
AU2012347261B2 (en) 2016-12-01
ZA201404100B (en) 2015-11-25
IN2014KN01211A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-10-16
CN104093721B (zh) 2016-05-18

Similar Documents

Publication Publication Date Title
ME02668B (me) Postupak za izdvajanje nalmefen hidrohlorida
ME02316B (me) Imidazopiridazini kao inhibitori akt kinaze
ME02622B (me) Pripremanje nalmefen hidrohlorida od naltreksona
JP2011126894A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX2015002752A (es) Metodo de preparación de una d,l-metionina limpia.
AU2012356770A8 (en) Polycarboxylic acid extraction
JP2017501141A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2013079507A3 (de) Verfahren zur herstellung und aufreinigung von salzen der acrylamido-2-methyl-propansulfonsäure
ME02621B (me) Postupak za proizvodnju naltreksona
JP2013100237A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN104003978B (zh) 贝他斯汀或其消旋化合物的工业化制备方法
HK1200458A1 (en) Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids
CN103936759A (zh) (3aS,6aR)-1,3-二苄基-四氢-4H-噻吩并[3,4-d]咪唑-2,4-(1H)-二酮的简便制备方法
CN103555969B (zh) 一种钾钠分离新方法
FI20106311A0 (fi) Menetelmä orgaanisen hapon talteenottamiseksi laimeasta vesiliuoksesta
EA201590558A1 (ru) Способ экстракции растворителем
HRP20171166T1 (hr) Postupak za pripravu intermedijera pirimidina
CN104892501A (zh) 一种3-[(3-氨基-4-甲氨基苯甲酰基)(吡啶-2-基)氨基]丙酸乙酯的后处理纯化方法
JP2016525094A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2012193074A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2008108442A1 (ja) 新規ポルフィラジン誘導体およびその中間体、新規ポルフィラジン誘導体およびその中間体の製造方法、並びにその利用
CN108610247A (zh) 6-氯-7-羟基-1-茚酮的制备方法
ATE536339T1 (de) Verfahren zur rückgewinnung von mineralsäuren bei der herstellung von diphenylmethandiamin
MX2019006363A (es) Metodo para la polialcoxilacion de acidos nucleicos que permite la recuperacion y reutilizacion del reactivo de polialcoxilacion en exceso.
CN104418792A (zh) 一种化合物6-甲基吲哚-3-甲醛的制备方法